Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

PJ Online | News: Pharmacists' prescribing training to start in spring

Home > PJ (current issue) > News / Daily News | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 269 No 7226 p768
30 November 2002

This article
Reprint
Photocopy


News summary

Related websites
DoH: Supplementary prescribing (more)


Pharmacists' prescribing training to start in spring

Lord Hunt (right) talks with Tony West, chief pharmacist for Guy’s and St Thomas’ Hospital Trust, during a visit to an anticoagulant clinic last week

Training for pharmacists to become supplementary prescribers will start in the spring of 2003, the Department of Health announced last week.

Regulations to permit pharmacist prescribing should be laid before Parliament ahead of its Christmas recess.

Lord Hunt, Parliamentary Under-Secretary of State for Health, visited an anticoagulant clinic at Guy's Hospital, London, on 21 November to mark the official go ahead for pharmacist prescribing and an extension of nurse prescribing (PJ, 23 November, p731). He said: "Staff will undergo comprehensive training before becoming supplementary prescribers. We aim to have up to 1,000 pharmacists and up to 10,000 nurses trained by the end of 2004." He said that further guidance will be issued in the new year. The Journal will take a closer look at the issue at that time.

According to the Department of Health, patients with asthma, diabetes, coronary heart disease and high blood pressure are likely to be among the first to benefit with quicker access to medicines. These patients will be able to have their medicines' doses, frequencies and formulations adjusted within limits set down in a written clinical management plan.

Back to Top

Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal

Citation: The Pharmaceutical Journal URI: 20008297

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Rate
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.